Description
BPC-157
Opinion Only. Not for Medical Reference. Written by Nevin Pratt
The FDA is meeting with the Pharmacy Compounding Advisory Committee (PCAC) on 7/23/26 to evaluate BPC-157 for the treatment of ulcerative colitis.
BPC is for soft tissue injury repair. Half life 6-8 hrs. Local injection at an injury site is best, but systemic (in the stomache area) works quite well too. People often mix this with TB-500 in the same vial, but I recommend against that. Those two peptides have a different PH and a different half life. Also different optimal dosing schedules. Keep them separate. A study on using BPC-157 for regeneration can be found here.
BPC-157 significantly stimulates epigenic change in over 100 types of genes, and does so very quickly. It’s biggest effect is in stimulating angiogenesis, or the building of capillaries and veins, which in turn helps growth and repair factors flow to damaged tissue. The way it does that is through influencing the genes that transcript nitric-oxide use. It improves how your body utilizes nitric oxide that’s existing, and how your body makes more nitric oxide more efficiently.
Here are a couple of Youtube short videos on it. The first is a Joe Rogan interview, and the second is from a well-known Stanford University professor, Dr. Andrew Huberman:
https://www.youtube.com/shorts/EVejn72GgQo
https://www.youtube.com/shorts/kOUvJVD_78U
Dr. Trevor Bachmeyer calls it a “forever peptide”, to be taken daily, and talks extensively about BPC-157 in this video:
https://youtu.be/nRi9GqTfGqY?si=bh2tuRTmX64_awQW
Here are some studies on it:
https://pubmed.ncbi.nlm.nih.gov/34267654/
https://pubmed.ncbi.nlm.nih.gov/40756949/
I believe that the claim that some have made regarding BPC-157 enabling cancer growth to be false. In a cancer study, here is an article showing that in vitro, BPC-157 stopped human melanoma cell growth and reduced VEGF signaling. https://journals.lww.com/melanomaresearch/citation/2004/08000/bpc_157_inhibits_cell_growth_and_vegf_signalling.50.aspx. And in mice with colon cancer cachexia, BPC-157 reduced muscle wasting and prolonged survival: https://pubmed.ncbi.nlm.nih.gov/29898649/
Dosage: 300mcg to 600mcg daily.
5mg vial with 2cc BAC = 20 units daily = 500mcg/dose.
10mg vial with 2cc BAC = 10 units daily = 500mcg/dose.
10mg vial with 3cc BAC = 10 units for 333mcg.
BPC-157 daily, and TB-500 every 3 to 5 days.
